ARCHIVES

In Brief: FDA Changes Package Inserts For Thiotepa, Cyclophosphamide, As Committee Suggested

This article is from The Cancer Letter archive.

Vol. 05 No. 35 | August 31, 1979

Download PDF Visit The Full Archive

Related Articles

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Avon Awards $30M To 13 Organizations

September 27, 2002

In Brief: Schilsky Succeeds McIntyre As CALB Chair; UC Irvine Awarded New Cancer Center Grants

November 11, 1994

NPCC Workshop Developed “Exciting List” Of Projects, Organizer Says

November 8, 1996

Senate Appropriators Plan Hearing On NCI Ouster Of Fisher

June 3, 1994